Risk Factors for Postoperative Urinary Retention After Lumbar Fusion Surgery: Anesthetics and Surgical Approach

医学 苏伽马德克斯 优势比 尿潴留 麻醉剂 置信区间 腰椎 逻辑回归 麻醉 体质指数 外科 内科学 插管 罗库溴铵
作者
Jeremy C. Heard,Yunsoo Lee,Mark J. Lambrechts,Teeto Ezeonu,Azra Dees,Bright M. Wiafe,Justin Wright,Gregory R. Toci,Eric S. Schwenk,José A. Canseco,I. David Kaye,Mark F. Kurd,Alan S. Hilibrand,Alexander R. Vaccaro,Gregory D. Schroeder,Christopher K. Kepler
标识
DOI:10.5435/jaaos-d-23-00172
摘要

Postoperative urinary retention (POUR) after lumbar fusion surgery can lead to longer hospital stays and thus increased risk of developing other postoperative complications. Therefore, we aimed to determine the relationship between POUR and (1) surgical approach and (2) anesthetic agents, including sugammadex and glycopyrrolate.After institutional review board approval, L4-S1 single-level lumbar fusion surgeries between 2018 and 2021 were identified. A 3:1 propensity match of patients with POUR to those without was conducted, controlling for patient age, sex, diabetes status, body mass index, smoking status, history of benign prostatic hyperplasia, and the number of levels decompressed. POUR was defined as documented straight catheterization yielding >400 mL. We compared patient demographic, surgical, anesthetic, and postoperative characteristics. A bivariant analysis and backward multivariable stepwise logistic regression analysis ( P -value < 0.200) were performed. Significance was set to P < 0.05.Of the 899 patients identified, 51 met the criteria for POUR and were matched to 153 patients. No notable differences were observed between groups based on demographic or surgical characteristics. On bivariant analysis, patients who developed POUR were more likely to have been given succinylcholine (13.7% vs. 3.92%, P = 0.020) as an induction agent. The independent predictors of POUR identified by multivariable analysis included the use of succinylcholine {odds ratio (OR), 4.37 (confidence interval [CI], 1.26 to 16.46), P = 0.022} and reduced postoperative activity (OR, 0.99 [CI, 0.993 to 0.999], P = 0.049). Factors protective against POUR included using sugammadex as a reversal agent (OR, 0.38 [CI, 0.17 to 0.82], P = 0.017). The stepwise regression did not identify an anterior surgical approach as a notable predictor of POUR.We demonstrate that sugammadex for anesthesia reversal was protective against POUR while succinylcholine and reduced postoperative activity were associated with the development of POUR. In addition, we found no difference between the anterior or posterior approach to spinal fusion in the development of POUR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1111完成签到,获得积分10
刚刚
刚刚
swsx1317发布了新的文献求助10
1秒前
camellia发布了新的文献求助10
1秒前
拼搏思卉发布了新的文献求助10
1秒前
captin发布了新的文献求助10
1秒前
lzzj完成签到,获得积分10
1秒前
yannis2020发布了新的文献求助10
1秒前
孤独秋白完成签到,获得积分10
1秒前
安详绿草发布了新的文献求助10
1秒前
喵喵完成签到 ,获得积分10
1秒前
楼寒天发布了新的文献求助10
2秒前
陈陌陌完成签到,获得积分10
2秒前
CipherSage应助科研通管家采纳,获得20
3秒前
丘比特应助标致小伙采纳,获得10
3秒前
咸鱼好翻身完成签到,获得积分10
3秒前
NexusExplorer应助科研通管家采纳,获得30
3秒前
北北完成签到 ,获得积分10
3秒前
3秒前
1221211应助科研通管家采纳,获得10
3秒前
3秒前
prosperp应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
剑兰先生应助科研通管家采纳,获得200
3秒前
Judy发布了新的文献求助10
3秒前
Shengwj完成签到,获得积分10
4秒前
科研通AI2S应助科研通管家采纳,获得30
4秒前
Ava应助科研通管家采纳,获得10
4秒前
勤奋沛珊应助科研通管家采纳,获得10
4秒前
大模型应助南城雨落采纳,获得10
4秒前
田様应助科研通管家采纳,获得10
4秒前
Owen应助科研通管家采纳,获得10
4秒前
852应助科研通管家采纳,获得10
4秒前
kingwill应助科研通管家采纳,获得20
4秒前
李健应助科研通管家采纳,获得10
4秒前
星辰大海应助科研通管家采纳,获得10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
BreezyGallery完成签到,获得积分10
4秒前
4秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527699
求助须知:如何正确求助?哪些是违规求助? 3107752
关于积分的说明 9286499
捐赠科研通 2805513
什么是DOI,文献DOI怎么找? 1539954
邀请新用户注册赠送积分活动 716878
科研通“疑难数据库(出版商)”最低求助积分说明 709759